NEW YORK ( TheStreet) -- Amyris (Nasdaq: AMRS) hit a new 52-week low Thursday as it is currently trading at $15.06, below its previous 52-week low of $15.21 with 27,314 shares traded as of 9:52 a.m. ET. Average volume has been 249,000 shares over the past 30 days.

Amyris has a market cap of $822.9 million and is part of the health care sector and drugs industry. Shares are down 42% year to date as of the close of trading on Wednesday.

Amyris, Inc., an integrated renewable products company, offers renewable compounds for a variety of markets.
  • Practice your AMRS trading strategies and win cash in our stock game.

TheStreet Ratings rates Amyris as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and poor profit margins. You can view the full Amyris Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.